1. Home
  2. FLGC vs CLDI Comparison

FLGC vs CLDI Comparison

Compare FLGC & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flora Growth Corp.

FLGC

Flora Growth Corp.

HOLD

Current Price

$9.75

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

HOLD

Current Price

$1.46

Market Cap

9.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLGC
CLDI
Founded
2019
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
9.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
FLGC
CLDI
Price
$9.75
$1.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.1K
80.8K
Earning Date
11-05-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$57,609,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.71
N/A
52 Week Low
$6.80
$1.10
52 Week High
$81.90
$23.16

Technical Indicators

Market Signals
Indicator
FLGC
CLDI
Relative Strength Index (RSI) 50.48 47.63
Support Level $9.28 $1.41
Resistance Level $11.17 $1.54
Average True Range (ATR) 1.42 0.08
MACD 0.43 0.01
Stochastic Oscillator 41.07 59.09

Price Performance

Historical Comparison
FLGC
CLDI

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

Share on Social Networks: